The Drug Discovery and Development process consists of several sequential steps that aim to ensure a safe and effective profile of a new drug candidate before market approval.
In particular, in the pre-clinical phase it is crucial to elucidate promising candidates to hopefully reach a clinical trial. The step that allows the passage between these two phases is defined as drug lead optimization, the final phase of the Drug Discovery process.
